BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32536614)

  • 1. Is reinfection possible after recovery from COVID-19?
    Law SK; Leung AWN; Xu C
    Hong Kong Med J; 2020 Jun; 26(3):264-265. PubMed ID: 32536614
    [No Abstract]   [Full Text] [Related]  

  • 2. The utility of beta-2-microglobulin testing as a human cellular control in COVID-19 testing.
    Davies E; Whitfield T; Machin N; Ahmad S
    J Clin Virol; 2020 Aug; 129():104449. PubMed ID: 32504943
    [No Abstract]   [Full Text] [Related]  

  • 3. Selecting a SARS-CoV-2/COVID Molecular Testing Method for Your Laboratory.
    Greene DN
    J Appl Lab Med; 2020 Jul; 5(4):837-840. PubMed ID: 32761155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Which sampling method for the upper respiratory tract specimen should be taken to diagnose patient with COVID-19?].
    Ye B; Fan C; Pan Y; Ding R; Hu HX; Xiang ML
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jun; 55(6):583-588. PubMed ID: 32166939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Nasopharyngeal Swab Comparable With Nasopharyngeal Aspirate to Detect SARS-CoV-2 in Children?
    Capecchi E; Di Pietro GM; Luconi E;
    Pediatr Infect Dis J; 2020 Sep; 39(9):e288-e289. PubMed ID: 32740453
    [No Abstract]   [Full Text] [Related]  

  • 6. Saliva as a Noninvasive Specimen for Detection of SARS-CoV-2.
    Williams E; Bond K; Zhang B; Putland M; Williamson DA
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32317257
    [No Abstract]   [Full Text] [Related]  

  • 7. Special Issue on Diagnostic Testing for Severe Acute Respiratory Syndrome Coronavirus 2 and Lessons from This Pandemic.
    McAdam AJ
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32703896
    [No Abstract]   [Full Text] [Related]  

  • 8. Saliva as an Alternate Specimen Source for Detection of SARS-CoV-2 in Symptomatic Patients Using Cepheid Xpert Xpress SARS-CoV-2.
    McCormick-Baw C; Morgan K; Gaffney D; Cazares Y; Jaworski K; Byrd A; Molberg K; Cavuoti D
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32414838
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 PCR Test, Cluster of False Positive and Importance of Quality Control.
    Joob B; Wiwantikit V
    Clin Lab; 2020 Oct; 66(10):. PubMed ID: 33073939
    [No Abstract]   [Full Text] [Related]  

  • 10. Sample collection and stabilization from saliva samples for SARS-CoV-2 detection by qPCR.
    Biotechniques; 2020 Sep; 69(3):237. PubMed ID: 32929994
    [No Abstract]   [Full Text] [Related]  

  • 11. What to Expect from Antibody Assays of SARS-CoV-2?
    Yi X; Cao J
    J Appl Lab Med; 2020 Sep; 5(5):1126-1130. PubMed ID: 32589736
    [No Abstract]   [Full Text] [Related]  

  • 12. Shifting sands-Molecular coronavirus testing during a time of inconsistent resources.
    Henderson DK; Hayden MK; Wright SB; Weber DJ; Murthy AR; Babcock H; Guzman-Cottrill JA; Haessler S; Rock C; Van Schooneveld T; Forde CA; Logan LK; Malani A;
    Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1190-1191. PubMed ID: 32498736
    [No Abstract]   [Full Text] [Related]  

  • 13. Validation of the Hologic Aptima Unisex and Multitest Specimen Collection Kits Used for Endocervical and Male Urethral Swab Specimens (Aptima Swabs) for Collection of Samples from SARS-CoV-2-Infected Patients.
    Avaniss-Aghajani E; Sarkissian A; Fernando F; Avaniss-Aghajani A
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32317256
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety considerations in the bioanalytical laboratories handling specimens from coronavirus disease 2019 patients.
    Chen Z; Sikorski TW
    Bioanalysis; 2020 Sep; 12(17):1219-1222. PubMed ID: 32820941
    [No Abstract]   [Full Text] [Related]  

  • 15. Willingness to Use Home Collection Methods to Provide Specimens for SARS-CoV-2/COVID-19 Research: Survey Study.
    Hall EW; Luisi N; Zlotorzynska M; Wilde G; Sullivan P; Sanchez T; Bradley H; Siegler AJ
    J Med Internet Res; 2020 Sep; 22(9):e19471. PubMed ID: 32790639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. My Experience with SARS-CoV-2, with a Focus on Testing.
    Cotter PA
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32703893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a Rapid Diagnostic Assay for Detection of SARS-CoV-2 Antigen in Nasopharyngeal Swabs.
    Lambert-Niclot S; Cuffel A; Le Pape S; Vauloup-Fellous C; Morand-Joubert L; Roque-Afonso AM; Le Goff J; Delaugerre C
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32404480
    [No Abstract]   [Full Text] [Related]  

  • 18. The Sampling Locations are Closely Related to the Positive Rate of Novel Coronavirus Nucleic Acid Detection.
    Wang D; Wang H; Li S; Ren T; Cao Z; Nie H; Chen Z; Ma W; Wu Y; Chen Z; Huang T; Song C; Zhou Y
    Clin Lab; 2020 Jun; 66(6):. PubMed ID: 32538065
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID-19 serologic testing: FAQs and caveats.
    Kadkhoda K
    Cleve Clin J Med; 2020 Jun; 87(6):329-333. PubMed ID: 32434807
    [No Abstract]   [Full Text] [Related]  

  • 20. Unilateral conjunctivitis as first presentation of Coronavirus Disease 2019 (COVID-19): A telemedicine diagnosis.
    Daruich A; Martin D; Bremond-Gignac D
    J Fr Ophtalmol; 2020 May; 43(5):e167-e168. PubMed ID: 32327279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.